Cooper Companies, Inc. (NYSE: COO)

The Cooper Companies, Inc. is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 7,000 employees with products sold in over 100 countries.

Cooper’s top line grew to $344.6 million, a modest 6% increase compared to last year. The company earns over 80% of its revenue from its eye-care division CooperVision, which recorded a 5% improvement in sales compared to last year, while sales at its surgical equipment division CooperSurgical climbed 13%, mainly helped by acquisitions.

Cooper recently announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 6, 2012, to stockholders of record on July 24, 2012.

The share of the Cooper Companies closed at $78.93 last Friday, above its 20-day moving average of $78.75 and below its 100-day moving average of $81.92 with 681,880 volume.It has been showing support at $72.44 and resistance in the $82.87 price range. It has been upgraded at stoxline.com to a strong buy.